These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 39058346)

  • 1. Early wound healing at 1 week postoperatively in periodontal tissue regeneration therapy: enamel matrix derivative versus recombinant human fibroblast growth factor.
    Nakayama Y; Ogihara-Takeda M; Saito Y; Yamaguchi A; Ogata Y
    J Periodontal Implant Sci; 2024 May; ():. PubMed ID: 39058346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of early wound healing using modified papilla preservation technique between enamel matrix derivative and recombinant human fibroblast growth factor.
    Nakayama Y; Tabe S; Igarashi K; Moriya S; Katsumata T; Kobayashi R; Nakagawa S; Nishino T; Fukuoka N; Hosono K; Yamasaki M; Yamazaki Y; Ogihara-Takeda M; Ito S; Saito Y; Yamaguchi A; Tsuruya Y; Yamazaki-Takai M; Yoshino S; Takai H; Ogata Y
    J Periodontal Implant Sci; 2024 Aug; 54(4):236-252. PubMed ID: 38014774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized Placebo-Controlled and Controlled Non-Inferiority Phase III Trials Comparing Trafermin, a Recombinant Human Fibroblast Growth Factor 2, and Enamel Matrix Derivative in Periodontal Regeneration in Intrabony Defects.
    Kitamura M; Akamatsu M; Kawanami M; Furuichi Y; Fujii T; Mori M; Kunimatsu K; Shimauchi H; Ogata Y; Yamamoto M; Nakagawa T; Sato S; Ito K; Ogasawara T; Izumi Y; Gomi K; Yamazaki K; Yoshie H; Fukuda M; Noguchi T; Takashiba S; Kurihara H; Nagata T; Hamachi T; Maeda K; Yokota M; Sakagami R; Hara Y; Noguchi K; Furuuchi T; Sasano T; Imai E; Ohmae M; Koizumi H; Watanuki M; Murakami S
    J Bone Miner Res; 2016 Apr; 31(4):806-14. PubMed ID: 26547659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of adjunctive procedures on recombinant human fibroblast growth factor-2-mediated periodontal regeneration therapy: A retrospective study.
    Nakayama Y; Matsuda H; Itoh S; Iwai Y; Takai H; Mezawa M; Yoshino S; Ogata Y
    J Periodontol; 2021 Jul; 92(7):983-994. PubMed ID: 33128399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of surgical flap design (minimally invasive flap vs. extended flap with papilla preservation) on the healing of intrabony defects treated with an enamel matrix derivative: a 12-month two-center randomized controlled clinical trial.
    Windisch P; Iorio-Siciliano V; Palkovics D; Ramaglia L; Blasi A; Sculean A
    Clin Oral Investig; 2022 Feb; 26(2):1811-1821. PubMed ID: 34491446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early wound healing outcomes after regenerative periodontal surgery with enamel matrix derivatives or guided tissue regeneration: a systematic review.
    Rojas MA; Marini L; Pilloni A; Sahrmann P
    BMC Oral Health; 2019 May; 19(1):76. PubMed ID: 31064353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of early discomfort and wound healing outcomes after periodontal surgery with and without enamel matrix derivative: an observational retrospective case-control study.
    Lee JH; Park YS; Kim YT; Kim DH; Jeong SN
    Clin Oral Investig; 2020 Jan; 24(1):229-237. PubMed ID: 31079246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical evaluation of demineralized freeze-dried bone allograft and enamel matrix derivative versus enamel matrix derivative alone for the treatment of periodontal osseous defects in humans.
    Gurinsky BS; Mills MP; Mellonig JT
    J Periodontol; 2004 Oct; 75(10):1309-18. PubMed ID: 15562907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microsurgical access flap and enamel matrix derivative for the treatment of periodontal intrabony defects: a controlled clinical study.
    Wachtel H; Schenk G; Böhm S; Weng D; Zuhr O; Hürzeler MB
    J Clin Periodontol; 2003 Jun; 30(6):496-504. PubMed ID: 12795787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of periodontal wound healing/regeneration by recombinant human fibroblast growth factor-2 combined with β-tricalcium phosphate, carbonate apatite, or deproteinized bovine bone mineral in a canine one-wall intra-bony defect model.
    Shirakata Y; Setoguchi F; Sena K; Nakamura T; Imafuji T; Shinohara Y; Iwata M; Noguchi K
    J Clin Periodontol; 2022 Jun; 49(6):599-608. PubMed ID: 35322457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apical approach in periodontal reconstructive surgery with enamel matrix derivate and enamel matrix derivate plus bone substitutes: a randomized, controlled clinical trial.
    Moreno Rodríguez JA; Ortiz Ruiz AJ
    Clin Oral Investig; 2022 Mar; 26(3):2793-2805. PubMed ID: 34791548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Five-year results evaluating the effects of platelet-rich plasma on the healing of intrabony defects treated with enamel matrix derivative and natural bone mineral.
    Döri F; Arweiler N; Húszár T; Gera I; Miron RJ; Sculean A
    J Periodontol; 2013 Nov; 84(11):1546-55. PubMed ID: 23327604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human periodontal fibroblast response to enamel matrix derivative, amelogenin, and platelet-derived growth factor-BB.
    Chong CH; Carnes DL; Moritz AJ; Oates T; Ryu OH; Simmer J; Cochran DL
    J Periodontol; 2006 Jul; 77(7):1242-52. PubMed ID: 16805689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levels of tissue inhibitor of metalloproteinases-1 and matrix metalloproteinases-1 and -8 in gingival crevicular fluid following treatment with enamel matrix derivative (EMDOGAIN).
    Okuda K; Miyazaki A; Momose M; Murata M; Nomura T; Kubota T; Wolff LF; Yoshie H
    J Periodontal Res; 2001 Oct; 36(5):309-16. PubMed ID: 11585118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical evaluation of wound healing following multiple exposures to enamel matrix protein derivative in the treatment of intrabony periodontal defects.
    Heard RH; Mellonig JT; Brunsvold MA; Lasho DJ; Meffert RM; Cochran DL
    J Periodontol; 2000 Nov; 71(11):1715-21. PubMed ID: 11128919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biodegradable gelatin/beta-tricalcium phosphate sponges incorporating recombinant human fibroblast growth factor-2 for treatment of recession-type defects: A split-mouth study in dogs.
    Shujaa Addin A; Akizuki T; Hoshi S; Matsuura T; Ikawa T; Fukuba S; Matsui M; Tabata Y; Izumi Y
    J Periodontal Res; 2017 Oct; 52(5):863-871. PubMed ID: 28345758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant human fibroblast growth factor and autogenous bone for periodontal regeneration: Alone or in combination? A randomized clinical trial.
    Kojima K; Kamata Y; Shimizu T; Sato S; Suzuki S; Takanashi Y; Hojo S; Yoshino T; Fuchida S; Tamura T; Minabe M; Kodama T; Kessoku T; Oyamada S
    J Periodontal Res; 2024 Jun; ():. PubMed ID: 38853125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth and amelogenin-like factors in periodontal wound healing. A systematic review.
    Giannobile WV; Somerman MJ
    Ann Periodontol; 2003 Dec; 8(1):193-204. PubMed ID: 14971254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro wound healing responses to enamel matrix derivative.
    Hoang AM; Oates TW; Cochran DL
    J Periodontol; 2000 Aug; 71(8):1270-7. PubMed ID: 10972642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparative study of epidermal growth factor and basic fibroblast growth factor on wound healing].
    Fu XB; Sun TZ; Wang YP
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 1999 Sep; 13(5):278-82. PubMed ID: 12080818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.